Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Soybean isoflavones in bone health.

Ishimi Y.

Forum Nutr. 2009;61:104-16. doi: 10.1159/000212743. Epub 2009 Apr 7. Review.

PMID:
19367115
2.

[Prevention of osteoporosis by foods and dietary supplements. Soybean isoflavone and bone metabolism].

Ishimi Y.

Clin Calcium. 2006 Oct;16(10):1661-67. Review. Japanese.

PMID:
17012819
3.

Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.

Yuan JP, Wang JH, Liu X.

Mol Nutr Food Res. 2007 Jul;51(7):765-81. Review.

PMID:
17579894
4.

[Nutrition and bone health. Isoflavones in bone health].

Ishimi Y.

Clin Calcium. 2009 Oct;19(10):1506-13. doi: CliCa091015061513. Review. Japanese.

PMID:
19794261
5.

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

Setchell KD, Brown NM, Lydeking-Olsen E.

J Nutr. 2002 Dec;132(12):3577-84. Review.

6.

Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice.

Ishimi Y.

J Nutr. 2010 Jul;140(7):1373S-6S. doi: 10.3945/jn.110.124842. Epub 2010 May 19.

7.

Soyfoods, soybean isoflavones, and bone health: a brief overview.

Messina M, Messina V.

J Ren Nutr. 2000 Apr;10(2):63-8. Review.

PMID:
10757817
8.
9.

Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial.

Wu J, Oka J, Higuchi M, Tabata I, Toda T, Fujioka M, Fuku N, Teramoto T, Okuhira T, Ueno T, Uchiyama S, Urata K, Yamada K, Ishimi Y.

Metabolism. 2006 Apr;55(4):423-33.

PMID:
16546471
10.
11.

Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice.

Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, Takeda K, Yamada K, Ishimi Y.

J Nutr. 2004 Oct;134(10):2623-7.

12.

Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial.

Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toda T, Uehara M, Ishimi Y.

Menopause. 2007 Sep-Oct;14(5):866-74.

PMID:
17464237
13.

Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data.

Messina M, Ho S, Alekel DL.

Curr Opin Clin Nutr Metab Care. 2004 Nov;7(6):649-58. Review.

PMID:
15534433
15.

Soy isoflavones in the management of postmenopausal osteoporosis.

Atmaca A, Kleerekoper M, Bayraktar M, Kucuk O.

Menopause. 2008 Jul-Aug;15(4 Pt 1):748-57. doi: 10.1097/gme.0b013e31815c1e7f. Review.

PMID:
18277912
16.

Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights.

Jackman KA, Woodman OL, Sobey CG.

Curr Med Chem. 2007;14(26):2824-30. Review.

PMID:
18045128
17.

[Nutrition and bone health. Soybean and soy foods, and bone health].

Kubota M, Shimizu H.

Clin Calcium. 2009 Oct;19(10):1514-9. doi: CliCa091015141519. Review. Japanese.

PMID:
19794262
18.

Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.

Atkinson C, Frankenfeld CL, Lampe JW.

Exp Biol Med (Maywood). 2005 Mar;230(3):155-70. Review.

PMID:
15734719
19.

Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?

Scheiber MD, Rebar RW.

Menopause. 1999 Fall;6(3):233-41. Review.

PMID:
10486794
20.

Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype?

Vatanparast H, Chilibeck PD.

Nutr Rev. 2007 Jun;65(6 Pt 1):294-9. Review.

PMID:
17605306

Supplemental Content

Support Center